Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers

Nicotine and Tobacco Research

Volumn 16, Issue 2, 2014, Pages 197-207

  Brown, Richard A ^a   Abrantes, Ana M ^a   Strong, David R ^b   Niaura, Raymond ^c   Kahler, Christopher W ^d   Miller, Ivan W ^a   Price, Lawrence H ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c American Legacy Foundation   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; NICOTINE PATCH; ANTIDEPRESSANT AGENT; NICOTINE GUM;

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; AGED; BEHAVIOR THERAPY; COMPLICATION; DOSE RESPONSE; DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; THERAPY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891678184     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntt134     Document Type: Article

References (50)

1. Allen, A. M., Prince, C. B., & Dietz, P. M. (2009). Postpartum depressive symptoms and smoking relapse. American Journal of Preventive Medicine, 36, 9-12. doi:10.1016/j.amepre.2008.09.020
2. Baumeister, R. F., Vohs, K. D., & Tice, D. M. (2007). The strength model of self-control. Current Directions in Psychological Science, 16, 351-355.
3. Benjet, C., Wagner, F. A., Borges, G. G., & Medina-Mora, M. E. (2004). The relationship of tobacco smoking with depressive symptomatology in the Third Mexican National Addictions Survey. Psychological Medicine, 34, 881-888. doi:10.1017/S0033291703001600
4. Blondal, T., Gudmundsson, L. J., Tomasson, K., Jonsdottir, D., Hilmarsdottir, H., Kristjansson, F., Bjornsdottir, U. S.(1999). The effects of fluoxetine combined with nicotine inhalers in smoking cessation-a randomized trial. Addiction, 94, 1007-1015. doi:10.1046/j.1360-0443.1999.94710076.x
5. Brown, C., Madden, P. A., Palenchar, D. R., & Cooper-Patrick, L. (2000). The association between depressive symptoms and cigarette smoking in an urban primary care sample. International Journal of Psychiatry in Medicine, 30, 15-26. doi:10.2190/NY79-CJ0H-VBAY-5M1U
6. Brown, R. A., Burgess, E. S., Sales, S. D., Whiteley, J. A., Evans, D. M., & Miller, I. W. (1998). Reliability and validity of a smoking timeline follow-back interview. Psychology of Addictive Behaviors, 12, 101-112. doi:10.1037//0893-164X.12.2.101
7. Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Sales, S. D., Ramsey, S. E., Miller, I. W. (2001). Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology, 69, 471-480. doi:10.1037/0022-006X.69.3.471
8. Brown, R. A., Niaura, R., Lloyd-Richardson, E. E., Strong, D.R., Kahler, C. W., Abrantes, A. M., Miller, I. W. (2007). Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine & Tobacco Research, 9, 721-730. doi:10.1080/14622200701416955
9. Burgess, E. S., Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Goldstein, M. G., & Miller, I. W. (2002). Patterns of change in depressive symptoms during smoking cessation: Who's at risk for relapse? Journal of Consulting and Clinical Psychology, 70, 356-361. doi:10.1037//0022-006X.70.2.356
10. Cook, J., Spring, B., McChargue, D., & Doran, N. (2010). Effects of anhedonia on days to relapse among smokers with a history of depression: A brief report. Nicotine & Tobacco Research, 12, 978-982. doi:10.1093/ntr/ntq118
11. Cook, J. W., Spring, B., McChargue, D. E., Borrelli, B., Hitsman, B., Niaura, R., Kristeller, J. (2004). Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial. Psychopharmacology, 173, 153-159. doi:10.1007/s00213-003-1711-8
12. Curtin, L., Brown, R. A., & Sales, S. D. (2000). Determinants of attrition from cessation treatment in smokers with a history of major depressive disorder. Psychology of Addictive Behaviors, 14, 134-142. doi:10.1037/0893-164X.14.2.134
13. Dalack, G. W., Glassman, A. H., Rivelli, S., Covey, L., & Stetner, F. (1995). Mood, major depression, and fluoxetine response in cigarette smokers. The American Journal of Psychiatry, 152, 398-403.
14. Doran, N., Spring, B., Borrelli, B., McChargue, D., Hitsman, B., Niaura, R., & Hedeker, D. (2006). Elevated positive mood: A mixed blessing for abstinence. Psychology of Addictive Behaviors, 20, 36-43. doi:10.1037/0893-164X.20.1.36
15. Finney Rutten, L. J., Wanke, K., & Augustson, E. (2005). Systems and individual factors associated with smoking status: Evidence from HINTS. American Journal of Health Behavior, 29, 302-310. doi:10.5993/AJHB.29.4.2
16. Fiore, M. C., Bailey, W. C., & Cohen, S. J., Dorfman, S. F., Goldstein, M. G., Gritz, E. G., Wewers, M. E. (2000). Treating tobacco use and dependence: Clinical practice guideline. Rockville, MD: U. S. Department of Health and Human Services. Public Health Service.
17. Fiore, M. C., Jaen, C. R., Baker, T. B., Bailey, W. C., Benowitz, N., Curry, S. J., Wewers, M. E. (2008). Treating tobacco use and dependence: Clinical practice guideline, 2008 update. Rockville, MD: U. S Department of Health and Human Services. Public Health Service.
18. Fiore, M. C., Smith, S. S., Jorenby, D. E., & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. The Journal of the American Medical Association, 271, 1940-1947. doi:10.1001/jama.271.24.1940
19. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W.(1995). Structured clinical interview for DSM-IV Axis I Disorders. New York: New York State Psychiatric Institute.
20. Güleç, M., Bakir, B., Ozer, M., Uçar, M., Kiliç, S., & Hasde, M. (2005). Association between cigarette smoking and depressive symptoms among military medical students in Turkey. Psychiatry Research, 134, 281-286. doi:10.1016/j.psychres.2003.02.001
21. Haas, A. L., Muñoz, R. F., Humfleet, G. L., Reus, V. I., & Hall, S. M. (2004). Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. Journal of Consulting and Clinical Psychology, 72, 563-570. doi:10.1037/0022-006X.72.4.563
22. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127. doi:10.1111/j.1360-0443.1991.tb01879.x
23. Hitsman, B., Pingitore, R., Spring, B., Mahableshwarkar, A., Mizes, J. S., Segraves, K. A., Xu, W. (1999). Antidepressant pharmacotherapy helps some cigarette smokers more than others. Journal of Consulting and Clinical Psychology, 67, 547-554. doi:10.1037/0022-006X.67.4.547
24. Hitsman, B., Spring, B., Borrelli, B., Niaura, R., & Papandonatos, G. D. (2001). Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine. Experimental and Clinical Psychopharmacology, 9, 355-362.
25. Højsgaard, S., Halekoh, U., & Yan, J. (2006). The R Package geepack for generalized estimating equations. Journal of Statistical Software, 15, 1-11. Retrieved from http://www.jstatsoft.org/v15/i02/v15i02.pdf
26. Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289-294. doi:10.1001/archpsyc.1986.01800030107013
27. Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E. (2003). Measures of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research, 5, 13-25. doi:10.1093/ntr/5.1.13
28. Hughes, J. R., Stead, L. F., & Lancaster, T. (2007). Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, CD000031. doi:10.1002/14651858.CD000031.pub3
29. Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987). Comparison of tests used to distinguish smokers from nonsmokers. American Journal of Public Health, 77, 1435-1438. doi:10.2105/AJPH.77.11.1435
30. Joseph, A. M., Willenbring, M. L., Nugent, S. M., & Nelson, D. B.(2004). A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. Journal of Studies on Alcohol, 65, 681-691.
31. Judd, L. L., Rapaport, M. H., Yonkers, K. A., Rush, A. J., Frank, E., Thase, M. E., Tollefson, G. (2004). Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. The American Journal of Psychiatry, 161, 1864-1871. doi:10.1176/appi.ajp.161.10.1864
32. Kenney, B. A., Holahan, C. J., North, R. J., & Holahan, C. K. (2006). Depressive symptoms and cigarette smoking in American workers. American Journal of Health Promotion, 20, 179-182. doi:10.4278/0890-1171-20.3.179
33. Kinnunen, T., Korhonen, T., & Garvey, A. J. (2008). Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: Twelve-month results of a randomized placebo controlled trial. International Journal of Psychiatry in Medicine, 38, 373-389.doi:10.2190/PM.38.3.k
34. Lerman, C., Roth, D., Kaufmann, V., Audrain, J., Hawk, L., Liu, A., Epstein, L. (2002). Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug and Alcohol Dependence, 67, 219-223. doi:10.1016/S0376-8716(02)00067-4
35. Leventhal, A. M., Ramsey, S. E., Brown, R. A., LaChance, H. R., & Kahler, C. W. (2008). Dimensions of depressive symptoms and smoking cessation. Nicotine & Tobacco Research, 10, 507-517. doi:10.1080/14622200801901971
36. Liang, K.-Y., & Zeger, S. L. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73, 13-22. doi:10.1093/biomet/73.1.13
37. MacPherson, L., Tull, M. T., Matusiewicz, A. K., Rodman, S., Strong, D. R., Kahler, C. W., Lejuez, C. W. (2010). Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. Journal of Consulting and Clinical Psychology, 78, 55-61. doi:10.1037/a0017939
38. McCaffery, J. M., Niaura, R., Swan, G. E., & Carmelli, D.(2003). A study of depressive symptoms and smoking behavior in adult male twins from the NHLBI twin study. Nicotine & Tobacco Research, 5, 77-83. doi:10.1080/14622200307259
39. Niaura, R., Spring, B., Borrelli, B., Hedeker, D., Goldstein, M. G., Keuthen, N.,... Abrams, D. B. (2002). Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. Journal of Consulting and Clinical Psychology, 70, 887-896.
40. Piasecki, T. M., Niaura, R., Shadel, W. G., Abrams, D., Goldstein, M., Fiore, M. C., & Baker, T. B. (2000). Smoking withdrawal dynamics in unaided quitters. Journal of Abnormal Psychology, 109, 74-86. doi:10.1037//0021-843X.109.1.74
41. R Core Team. (2011). R: A language and environment for statistical computing. Vienna, Austria. Retrieved from http://www.R-project.org/
42. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401. doi:10.1177/014662167700100306
43. Schnoll, R. A., Patterson, F., Wileyto, E. P., Heitjan, D.F., Shields, A. E., Asch, D. A., & Lerman, C. (2010). Effectiveness of extended-duration transdermal nicotine therapy: A randomized trial. Annals of Internal Medicine, 152, 144-151. doi:10.1059/0003-4819-152-3-201002020-00005
44. Spring, B., Doran, N., Pagoto, S., McChargue, D., Cook, J. W., Bailey, K., Hedeker, D. (2007). Fluoxetine, smoking, and history of major depression: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 75, 85-94. doi:10.1037/0022-006X.75.1.85
45. Spring, B., Pagoto, S., Pingitore, R., Doran, N., Schneider, K., & Hedeker, D. (2004). Randomized controlled trial for behavioral smoking and weight control treatment: Effect of concurrent versus sequential intervention. Journal of Consulting and Clinical Psychology, 72, 785-796. doi:10.1037/0022-006X.72.5.785
46. SRNT Subcommittee on Biochemical Verification. (2002). Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research, 4, 149-159. doi:10.1080/14622200210123581
47. Thorndike, A. N., Regan, S., McKool, K., Pasternak, R. C., Swartz, S., Torres-Finnerty, N., & Rigotti, N. A. (2008). Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Archives of Internal Medicine, 168, 186-191. doi:10.1001/archinternmed.2007.60
48. Thorndike, A. N., Stafford, R. S., & Rigotti, N. A. (2001). US physicians' treatment of smoking in outpatients with psychiatric diagnoses. Nicotine & Tobacco Research, 3, 85-91. doi:10.1080/14622200020032132
49. United States Department of Health and Human Services.(1995). Clearing the Air: How to quit smoking... and quit for keeps (pp. 1-24). Washington, D.C.: Public Health Service, National Institutes of Health, National Cancer Institute.
50. Wei, I. (1978). Application of an urn model to the design of sequential controlled clinical trials. Journal of the American Statistical Association, 73, 559-563. doi:10.1080/01621459.1978.10480054